{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T13:01:12Z","timestamp":1789995672212,"version":"4.0.1"},"reference-count":135,"publisher":"Walter de Gruyter GmbH","issue":"3","license":[{"start":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:00:00Z","timestamp":1784851200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,25]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Cryptococcal meningoencephalitis (CME) remains a leading cause of AIDS-related mortality, and up to one-quarter of persons living with HIV who survive CME develop cryptococcal immune reconstitution inflammatory syndrome (CME-IRIS) after antiretroviral therapy (ART) initiation. CME-IRIS arises when recovering immunity encounters a high residual fungal antigen burden, yet the temporal adaptive immune dynamics that distinguish protective reconstitution from damaging neuroinflammation are not fully defined. This review synthesizes clinical and experimental data to propose a temporal framework centered on CD4\n                    <jats:sup>+<\/jats:sup>\n                    \u202fT cell polarization, regulatory failure, memory T cell quality, and T-B cell coordination. Before ART, many patients exhibit a Th2-skewed, low-inflammatory state with impaired Th1 responses, reduced antifungal IgM production, and deficient Tfh-B cell coordination, collectively favoring persistent\n                    <jats:italic>Cryptococcus neoformans<\/jats:italic>\n                    antigen burden. With ART, IL-7-driven T cell recovery, Th17\/Treg imbalance, Th1\/Th17-biased memory responses, and chemokine-guided trafficking of CXCR3\n                    <jats:sup>+<\/jats:sup>\n                    CCR5\n                    <jats:sup>+<\/jats:sup>\n                    effector cells into the central nervous system can convert this antigen-rich milieu into fulminant neuroinflammation. We further discuss emerging mouse models that recapitulate unmasking CME-IRIS, the contrasting immune profile of\n                    <jats:italic>Cryptococcus gattii<\/jats:italic>\n                    -associated IRIS as a comparative model, and developing therapeutic strategies that include targeted immunomodulators, cell-based therapies, and vaccines. Finally, we highlight future directions \u2013 particularly single-cell and spatial transcriptomic profiling of blood and CSF \u2013 to resolve which adaptive immune populations drive neuroinflammation and to validate predictive biomarkers for CME-IRIS. A temporally informed view of adaptive immunity in CME-IRIS may refine ART timing, guide risk stratification, and identify new adjunctive interventions for cryptococcosis and related IRIS syndromes.\n                  <\/jats:p>","DOI":"10.1515\/nipt-2026-0016","type":"journal-article","created":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T05:55:42Z","timestamp":1784872542000},"page":"351-366","source":"Crossref","is-referenced-by-count":0,"title":["Temporal shifts in\u00a0adaptive immunity drive HIV-associated cryptococcal IRIS: mechanisms, models, and\u00a0therapeutic opportunities"],"prefix":"10.1515","volume":"5","author":[{"given":"Marcus","family":"Hunter","sequence":"first","affiliation":[{"name":"Department of Oral Biology , University of Florida College of Dentistry , Gainesville , FL , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6372-6501","authenticated-orcid":false,"given":"Luis R.","family":"Martinez","sequence":"additional","affiliation":[{"name":"Department of Oral Biology , University of Florida College of Dentistry , Gainesville , FL , USA"},{"name":"Emerging Pathogens Institute , Gainesville , FL , USA"},{"name":"Center for Immunology and Transplantation , Gainesville , FL , USA"},{"name":"McKnight Brain Institute , Gainesville , FL , USA"},{"name":"Center for Translational Research in Neurodegenerative Disease , University of Florida , Gainesville , FL , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2026,7,24]]},"reference":[{"key":"2026092111571358795_j_nipt-2026-0016_ref_001","doi-asserted-by":"crossref","unstructured":"Dao, A, Kim, HY, Garnham, K, Kidd, S, Sati, H, Perfect, J, et al.. Cryptococcosis-a systematic review to inform the World Health Organization fungal priority pathogens list. Med Mycol 2024;62. https:\/\/doi.org\/10.1093\/mmy\/myae043.","DOI":"10.1093\/mmy\/myae043"},{"key":"2026092111571358795_j_nipt-2026-0016_ref_002","doi-asserted-by":"crossref","unstructured":"Rajasingham, R, Govender, NP, Jordan, A, Loyse, A, Shroufi, A, Denning, DW, et al.. The global burden of HIV-associated cryptococcal infection in adults in 2020: a modelling analysis. Lancet Infect Dis 2022;22:1748\u201355. https:\/\/doi.org\/10.1016\/s1473-3099(22)00499-6.","DOI":"10.1016\/S1473-3099(22)00499-6"},{"key":"2026092111571358795_j_nipt-2026-0016_ref_003","doi-asserted-by":"crossref","unstructured":"Perfect, JR, Dismukes, WE, Dromer, F, Goldman, DL, Graybill, JR, Hamill, RJ, et al.. Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of America. Clin Infect Dis 2010;50:291\u2013322. https:\/\/doi.org\/10.1086\/649858.","DOI":"10.1086\/649858"},{"key":"2026092111571358795_j_nipt-2026-0016_ref_004","doi-asserted-by":"crossref","unstructured":"Howard-Jones, AR, Sparks, R, Pham, D, Halliday, C, Beardsley, J, Chen, SC. Pulmonary cryptococcosis. J Fungi 2022;8. https:\/\/doi.org\/10.3390\/jof8111156.","DOI":"10.3390\/jof8111156"},{"key":"2026092111571358795_j_nipt-2026-0016_ref_005","doi-asserted-by":"crossref","unstructured":"Emmons, CW. Saprophytic sources of Cryptococcus neoformans associated with the pigeon (Columba livia). Am J Hyg 1955;62:227\u201332. https:\/\/doi.org\/10.1093\/oxfordjournals.aje.a119775.","DOI":"10.1093\/oxfordjournals.aje.a119775"},{"key":"2026092111571358795_j_nipt-2026-0016_ref_006","doi-asserted-by":"crossref","unstructured":"Lazera, MS, Pires, FD, Camillo-Coura, L, Nishikawa, MM, Bezerra, CC, Trilles, L, et al.. Natural habitat of Cryptococcus neoformans var. neoformans in decaying wood forming hollows in living trees. J Med Vet Mycol 1996;34:127\u201331. https:\/\/doi.org\/10.1080\/02681219680000191.","DOI":"10.1080\/02681219680000191"},{"key":"2026092111571358795_j_nipt-2026-0016_ref_007","doi-asserted-by":"crossref","unstructured":"Ye, F, Xie, JX, Zeng, QS, Chen, GQ, Zhong, SQ, Zhong, NS. Retrospective analysis of 76 immunocompetent patients with primary pulmonary cryptococcosis. Lung 2012;190:339\u201346. https:\/\/doi.org\/10.1007\/s00408-011-9362-8.","DOI":"10.1007\/s00408-011-9362-8"},{"key":"2026092111571358795_j_nipt-2026-0016_ref_008","doi-asserted-by":"crossref","unstructured":"Zavala, S, Baddley, JW. Cryptococcosis. Semin Respir Crit Care Med 2020;41:69\u201379. https:\/\/doi.org\/10.1055\/s-0039-3400280.","DOI":"10.1055\/s-0039-3400280"},{"key":"2026092111571358795_j_nipt-2026-0016_ref_009","doi-asserted-by":"crossref","unstructured":"Cameron, ML, Bartlett, JA, Gallis, HA, Waskin, HA. Manifestations of pulmonary cryptococcosis in patients with acquired immunodeficiency syndrome. Rev Infect Dis 1991;13:64\u20137. https:\/\/doi.org\/10.1093\/clinids\/13.1.64.","DOI":"10.1093\/clinids\/13.1.64"},{"key":"2026092111571358795_j_nipt-2026-0016_ref_010","doi-asserted-by":"crossref","unstructured":"Chechani, V, Kamholz, SL. Pulmonary manifestations of disseminated cryptococcosis in patients with AIDS. Chest 1990;98:1060\u20136. https:\/\/doi.org\/10.1378\/chest.98.5.1060.","DOI":"10.1378\/chest.98.5.1060"},{"key":"2026092111571358795_j_nipt-2026-0016_ref_011","doi-asserted-by":"crossref","unstructured":"Meyohas, MC, Roux, P, Bollens, D, Chouaid, C, Rozenbaum, W, Meynard, JL, et al.. Pulmonary cryptococcosis: localized and disseminated infections in 27 patients with AIDS. Clin Infect Dis 1995;21:628\u201333. https:\/\/doi.org\/10.1093\/clinids\/21.3.628.","DOI":"10.1093\/clinids\/21.3.628"},{"key":"2026092111571358795_j_nipt-2026-0016_ref_012","doi-asserted-by":"crossref","unstructured":"Visnegarwala, F, Graviss, EA, Lacke, CE, Dural, AT, Johnson, PC, Atmar, RL, et al.. Acute respiratory failure associated with cryptococcosis in patients with AIDS: analysis of predictive factors. Clin Infect Dis 1998;27:1231\u20137. https:\/\/doi.org\/10.1086\/514984.","DOI":"10.1086\/514984"},{"key":"2026092111571358795_j_nipt-2026-0016_ref_013","doi-asserted-by":"crossref","unstructured":"Henao-Martinez, AF, Beckham, JD. Cryptococcosis in solid organ transplant recipients. Curr Opin Infect Dis 2015;28:300\u20137. https:\/\/doi.org\/10.1097\/qco.0000000000000171.","DOI":"10.1097\/QCO.0000000000000171"},{"key":"2026092111571358795_j_nipt-2026-0016_ref_014","doi-asserted-by":"crossref","unstructured":"Wang, LR, Barber, CE, Johnson, AS, Barnabe, C. Invasive fungal disease in systemic lupus erythematosus: a systematic review of disease characteristics, risk factors, and prognosis. Semin Arthritis Rheum 2014;44:325\u201330. https:\/\/doi.org\/10.1016\/j.semarthrit.2014.06.001.","DOI":"10.1016\/j.semarthrit.2014.06.001"},{"key":"2026092111571358795_j_nipt-2026-0016_ref_015","doi-asserted-by":"crossref","unstructured":"Baddley, JW, Perfect, JR, Oster, RA, Larsen, RA, Pankey, GA, Henderson, H, et al.. Pulmonary cryptococcosis in patients without HIV infection: factors associated with disseminated disease. Eur J Clin Microbiol Infect Dis 2008;27:937\u201343. https:\/\/doi.org\/10.1007\/s10096-008-0529-z.","DOI":"10.1007\/s10096-008-0529-z"},{"key":"2026092111571358795_j_nipt-2026-0016_ref_016","doi-asserted-by":"crossref","unstructured":"Cancelli, I, Merlino, G, Serafini, A, Valente, M, Gigli, GL. Sarcoidosis as risk factor for cryptococcal meningitis in an apparently immunocompetent patient. Neurol Sci 2008;29:33\u20135. https:\/\/doi.org\/10.1007\/s10072-008-0856-y.","DOI":"10.1007\/s10072-008-0856-y"},{"key":"2026092111571358795_j_nipt-2026-0016_ref_017","doi-asserted-by":"crossref","unstructured":"Lin, YY, Shiau, S, Fang, CT. Risk factors for invasive Cryptococcus neoformans diseases: a case-control study. PLoS One 2015;10:e0119090. https:\/\/doi.org\/10.1371\/journal.pone.0119090.","DOI":"10.1371\/journal.pone.0119090"},{"key":"2026092111571358795_j_nipt-2026-0016_ref_018","doi-asserted-by":"crossref","unstructured":"Maziarz, EK, Perfect, JR. Cryptococcosis. Infect Dis Clin North Am 2016;30:179\u2013206. https:\/\/doi.org\/10.1016\/j.idc.2015.10.006.","DOI":"10.1016\/j.idc.2015.10.006"},{"key":"2026092111571358795_j_nipt-2026-0016_ref_019","doi-asserted-by":"crossref","unstructured":"Graybill, JR, Sobel, J, Saag, M, van Der Horst, C, Powderly, W, Cloud, G, et al.. Diagnosis and management of increased intracranial pressure in patients with AIDS and cryptococcal meningitis. The NIAID mycoses study group and AIDS cooperative treatment groups. Clin Infect Dis 2000;30:47\u201354. https:\/\/doi.org\/10.1086\/313603.","DOI":"10.1086\/313603"},{"key":"2026092111571358795_j_nipt-2026-0016_ref_020","doi-asserted-by":"crossref","unstructured":"Cheng, HE, Yeh, HZ, Yang, CS, Yang, SS, Liao, SC. Disseminated cryptococcus over pancreas, lung, and brain: a case report. J Med Case Rep 2024;18:513. https:\/\/doi.org\/10.1186\/s13256-024-04836-1.","DOI":"10.1186\/s13256-024-04836-1"},{"key":"2026092111571358795_j_nipt-2026-0016_ref_021","unstructured":"Marthy, HJ. The cephalopod egg, a suitable material for cell and tissue interaction studies. Prog Clin Biol Res 1982;85:223\u201333."},{"key":"2026092111571358795_j_nipt-2026-0016_ref_022","doi-asserted-by":"crossref","unstructured":"O\u2019Brien, L, Carmichael, J, Lowrie, DB, Andrew, PW. Strains of mycobacterium tuberculosis differ in susceptibility to reactive nitrogen intermediates in vitro. Infect Immun 1994;62:5187\u201390. https:\/\/doi.org\/10.1128\/iai.62.11.5187-5190.1994.","DOI":"10.1128\/iai.62.11.5187-5190.1994"},{"key":"2026092111571358795_j_nipt-2026-0016_ref_023","doi-asserted-by":"crossref","unstructured":"Siddiqui, TJ, Zamani, T, Parada, JP. Primary cryptococcal prostatitis and correlation with serum prostate specific antigen in a renal transplant recipient. J Infect 2005;51:e153\u20137. https:\/\/doi.org\/10.1016\/j.jinf.2004.12.005.","DOI":"10.1016\/j.jinf.2004.12.005"},{"key":"2026092111571358795_j_nipt-2026-0016_ref_024","unstructured":"WH Organization. Guidelines for diagnosing, preventing and managing cryptococcal disease among adults, adolescents and children living with HIV; 2022. https:\/\/www.who.int\/publications\/i\/item\/9789240052178 [Accessed 05 May 2026]."},{"key":"2026092111571358795_j_nipt-2026-0016_ref_025","doi-asserted-by":"crossref","unstructured":"Chang, CC, Harrison, TS, Bicanic, TA, Chayakulkeeree, M, Sorrell, TC, Warris, A, et al.. Global guideline for the diagnosis and management of cryptococcosis: an initiative of the ECMM and ISHAM in cooperation with the ASM. Lancet Infect Dis 2024;24:e495\u201312. https:\/\/doi.org\/10.1016\/s1473-3099(23)00731-4.","DOI":"10.1016\/S1473-3099(23)00731-4"},{"key":"2026092111571358795_j_nipt-2026-0016_ref_026","doi-asserted-by":"crossref","unstructured":"Gandhi, RT, Landovitz, RJ, Sax, PE, Smith, DM, Springer, SA, Gunthard, HF, et al.. Antiretroviral drugs for treatment and prevention of HIV in adults: 2024 recommendations of the international antiviral society-USA panel. JAMA 2025;333:609\u201328. https:\/\/doi.org\/10.1001\/jama.2024.24543.","DOI":"10.1001\/jama.2024.24543"},{"key":"2026092111571358795_j_nipt-2026-0016_ref_027","doi-asserted-by":"crossref","unstructured":"Aggarwal, N, Barclay, W, Shinohara, ML. Understanding mechanisms underlying the pathology of immune reconstitution inflammatory syndrome (IRIS) by using animal models. Curr Clin Microbiol Rep 2018;5:201\u20139. https:\/\/doi.org\/10.1007\/s40588-018-0099-5.","DOI":"10.1007\/s40588-018-0099-5"},{"key":"2026092111571358795_j_nipt-2026-0016_ref_028","doi-asserted-by":"crossref","unstructured":"Elston, JW, Thaker, H. Immune reconstitution inflammatory syndrome. Int J STD AIDS 2009;20:221\u20134. https:\/\/doi.org\/10.1258\/ijsa.2008.008449.","DOI":"10.1258\/ijsa.2008.008449"},{"key":"2026092111571358795_j_nipt-2026-0016_ref_029","doi-asserted-by":"crossref","unstructured":"Pirofski, LA, Casadevall, A. The damage-response framework of microbial pathogenesis and infectious diseases. Adv Exp Med Biol 2008;635:135\u201346.","DOI":"10.1007\/978-0-387-09550-9_11"},{"key":"2026092111571358795_j_nipt-2026-0016_ref_030","doi-asserted-by":"crossref","unstructured":"Pirofski, LA, Casadevall, A. Immune-mediated damage completes the parabola: Cryptococcus neoformans pathogenesis can reflect the outcome of a weak or strong immune response. mBio 2017;8. https:\/\/doi.org\/10.1128\/mbio.02063-17.","DOI":"10.1128\/mBio.02063-17"},{"key":"2026092111571358795_j_nipt-2026-0016_ref_031","doi-asserted-by":"crossref","unstructured":"Gaillet, A, Calin, R, Imbert, S, Ollivier, M, Guillot, H, Fekkar, A, et al.. Distinct paradoxical inflammatory reaction followed by postantiretroviral therapy immune reconstitution syndrome in cryptococcal meningitis. AIDS 2018;32:2434\u20136. https:\/\/doi.org\/10.1097\/qad.0000000000001994.","DOI":"10.1097\/QAD.0000000000001994"},{"key":"2026092111571358795_j_nipt-2026-0016_ref_032","doi-asserted-by":"crossref","unstructured":"Le, LT, Spudich, SS. HIV-associated neurologic disorders and central nervous system opportunistic infections in HIV. Semin Neurol 2016;36:373\u201381. https:\/\/doi.org\/10.1055\/s-0036-1585454.","DOI":"10.1055\/s-0036-1585454"},{"key":"2026092111571358795_j_nipt-2026-0016_ref_033","doi-asserted-by":"crossref","unstructured":"Meya, DB, Williamson, PR. Cryptococcal disease in diverse hosts. N Engl J Med 2024;390:1597\u2013610. https:\/\/doi.org\/10.1056\/nejmra2311057.","DOI":"10.1056\/NEJMra2311057"},{"key":"2026092111571358795_j_nipt-2026-0016_ref_034","doi-asserted-by":"crossref","unstructured":"Sereti, I, Sheikh, V, Shaffer, D, Phanuphak, N, Gabriel, E, Wang, J, et al.. Prospective international study of incidence and predictors of immune reconstitution inflammatory syndrome and death in people living with human immunodeficiency virus and severe lymphopenia. Clin Infect Dis 2020;71:652\u201360. https:\/\/doi.org\/10.1093\/cid\/ciz877.","DOI":"10.1093\/cid\/ciz877"},{"key":"2026092111571358795_j_nipt-2026-0016_ref_035","doi-asserted-by":"crossref","unstructured":"Rhein, J, Hullsiek, KH, Evans, EE, Tugume, L, Nuwagira, E, Ssebambulidde, K, et al.. Detrimental outcomes of unmasking cryptococcal meningitis with recent ART initiation. Open Forum Infect Dis 2018;5:ofy122. https:\/\/doi.org\/10.1093\/ofid\/ofy122.","DOI":"10.1093\/ofid\/ofy122"},{"key":"2026092111571358795_j_nipt-2026-0016_ref_036","doi-asserted-by":"crossref","unstructured":"Haddow, LJ, Colebunders, R, Meintjes, G, Lawn, SD, Elliott, JH, Manabe, YC, et al.., International Network for the Study of HIVaI. Cryptococcal immune reconstitution inflammatory syndrome in HIV-1-infected individuals: proposed clinical case definitions. Lancet Infect Dis 2010;10:791\u2013802. https:\/\/doi.org\/10.1016\/s1473-3099(10)70170-5.","DOI":"10.1016\/S1473-3099(10)70170-5"},{"key":"2026092111571358795_j_nipt-2026-0016_ref_037","doi-asserted-by":"crossref","unstructured":"Musubire, A, Kagimu, E, Mugabi, T, Meya, DB, Boulware, DR, Bahr, NC. Complex decisions in HIV-related cryptococcosis: addressing second episodes of cryptococcal meningitis. Curr HIV AIDS Rep 2024;21:75\u201385. https:\/\/doi.org\/10.1007\/s11904-024-00691-3.","DOI":"10.1007\/s11904-024-00691-3"},{"key":"2026092111571358795_j_nipt-2026-0016_ref_038","unstructured":"Nunnari, G, Gussio, M, Pinzone, MR, Martellotta, F, Cosentino, S, Cacopardo, B, et al.. Cryptococcal meningitis in an HIV-1-infected person: relapses or IRIS? Case report and review of the literature. Eur Rev Med Pharmacol Sci 2013;17:1555\u20139."},{"key":"2026092111571358795_j_nipt-2026-0016_ref_039","doi-asserted-by":"crossref","unstructured":"Williamson, PR, Jarvis, JN, Panackal, AA, Fisher, MC, Molloy, SF, Loyse, A, et al.. Cryptococcal meningitis: epidemiology, immunology, diagnosis and therapy. Nat Rev Neurol 2017;13:13\u201324. https:\/\/doi.org\/10.1038\/nrneurol.2016.167.","DOI":"10.1038\/nrneurol.2016.167"},{"key":"2026092111571358795_j_nipt-2026-0016_ref_040","doi-asserted-by":"crossref","unstructured":"Wu, G, Guo, X, Wang, Y, Hu, Z. Clinical and radiographic features of Cryptococcal neoformans meningitis-associated immune reconstitution inflammatory syndrome. Sci Rep 2020;10:9948. https:\/\/doi.org\/10.1038\/s41598-020-67031-4.","DOI":"10.1038\/s41598-020-67031-4"},{"key":"2026092111571358795_j_nipt-2026-0016_ref_041","doi-asserted-by":"crossref","unstructured":"Boulware, DR, Meya, DB, Bergemann, TL, Wiesner, DL, Rhein, J, Musubire, A, et al.. Clinical features and serum biomarkers in HIV immune reconstitution inflammatory syndrome after cryptococcal meningitis: a prospective cohort study. PLoS Med 2010;7:e1000384. https:\/\/doi.org\/10.1371\/journal.pmed.1000384.","DOI":"10.1371\/journal.pmed.1000384"},{"key":"2026092111571358795_j_nipt-2026-0016_ref_042","doi-asserted-by":"crossref","unstructured":"Meya, DB, Okurut, S, Zziwa, G, Cose, S, Boulware, DR, Janoff, EN. HIV-Associated cryptococcal immune reconstitution inflammatory syndrome is associated with aberrant T cell function and increased cytokine responses. J Fungi 2019;5. https:\/\/doi.org\/10.3390\/jof5020042.","DOI":"10.20944\/preprints201904.0086.v1"},{"key":"2026092111571358795_j_nipt-2026-0016_ref_043","doi-asserted-by":"crossref","unstructured":"Scemla, A, Gerber, S, Duquesne, A, Parize, P, Martinez, F, Anglicheau, D, et al.. Dramatic improvement of severe cryptococcosis-induced immune reconstitution syndrome with adalimumab in a renal transplant recipient. Am J Transplant 2015;15:560\u20134. https:\/\/doi.org\/10.1111\/ajt.13002.","DOI":"10.1111\/ajt.13002"},{"key":"2026092111571358795_j_nipt-2026-0016_ref_044","doi-asserted-by":"crossref","unstructured":"Gheuens, S, Smith, DR, Wang, X, Alsop, DC, Lenkinski, RE, Koralnik, IJ. Simultaneous PML-IRIS after discontinuation of natalizumab in a patient with MS. Neurology 2012;78:1390\u20133. https:\/\/doi.org\/10.1212\/wnl.0b013e318253d61e.","DOI":"10.1212\/WNL.0b013e318253d61e"},{"key":"2026092111571358795_j_nipt-2026-0016_ref_045","doi-asserted-by":"crossref","unstructured":"Chen, S, Sorrell, T, Nimmo, G, Speed, B, Currie, B, Ellis, D, et al.. Australasian Cryptococcal Study Group. Epidemiology and host- and variety-dependent characteristics of infection due to Cryptococcus neoformans in Australia and New Zealand. Clin Infect Dis 2000;31:499\u2013508. https:\/\/doi.org\/10.1086\/313992.","DOI":"10.1086\/313992"},{"key":"2026092111571358795_j_nipt-2026-0016_ref_046","doi-asserted-by":"crossref","unstructured":"Sorrell, TC, Davis, JM. Reconsidering the blood-brain barrier: histopathology and microanatomy of cryptococcal CNS infection. Microbiol Mol Biol Rev 2025;89:e0007825. https:\/\/doi.org\/10.1128\/mmbr.00078-25.","DOI":"10.1128\/mmbr.00078-25"},{"key":"2026092111571358795_j_nipt-2026-0016_ref_047","doi-asserted-by":"crossref","unstructured":"Campos, ALS, Pinheiro, KS, Rassele, ML, Rosa-Junior, M. The spectrum of radiological findings in neurocryptococcosis: case series and systematic review. Radiol Bras 2025;58:e20240107. https:\/\/doi.org\/10.1590\/0100-3984.2024.0107.","DOI":"10.1590\/0100-3984.2024.0107"},{"key":"2026092111571358795_j_nipt-2026-0016_ref_048","doi-asserted-by":"crossref","unstructured":"Xia, S, Li, X, Shi, Y, Liu, J, Zhang, M, Gu, T, et al.. A retrospective cohort study of lesion distribution of HIV-1 infection patients with cryptococcal meningoencephalitis on MRI: correlation with immunity and immune reconstitution. Medicine 2016;95:e2654. https:\/\/doi.org\/10.1097\/md.0000000000002654.","DOI":"10.1097\/MD.0000000000002654"},{"key":"2026092111571358795_j_nipt-2026-0016_ref_049","doi-asserted-by":"crossref","unstructured":"Song, W, Liu, L, Qi, T, Wang, Z, Tang, Y, Sun, J, et al.. Analysis of intracranial lesions in patients with HIV-associated cryptococcal meningitis. Front Cell Infect Microbiol 2025;15:1446470. https:\/\/doi.org\/10.3389\/fcimb.2025.1446470.","DOI":"10.3389\/fcimb.2025.1446470"},{"key":"2026092111571358795_j_nipt-2026-0016_ref_050","doi-asserted-by":"crossref","unstructured":"Lee, SC, Dickson, DW, Casadevall, A. Pathology of cryptococcal meningoencephalitis: analysis of 27 patients with pathogenetic implications. Hum Pathol 1996;27:839\u201347. https:\/\/doi.org\/10.1016\/s0046-8177(96)90459-1.","DOI":"10.1016\/S0046-8177(96)90459-1"},{"key":"2026092111571358795_j_nipt-2026-0016_ref_051","doi-asserted-by":"crossref","unstructured":"Hamed, MF, Araujo, GRS, Munzen, ME, Reguera-Gomez, M, Epstein, C, Lee, HH, et al.. Phospholipase B is critical for Cryptococcus neoformans survival in the central nervous system. mBio 2023;14:e0264022. https:\/\/doi.org\/10.1128\/mbio.02640-22.","DOI":"10.1128\/mbio.02640-22"},{"key":"2026092111571358795_j_nipt-2026-0016_ref_052","doi-asserted-by":"crossref","unstructured":"Hamed, MF, Enriquez, V, Munzen, ME, Charles-Nino, CL, Mihu, MR, Khoshbouei, H, et al.. Clinical and pathological characterization of central nervous system cryptococcosis in an experimental mouse model of stereotaxic intracerebral infection. PLoS Negl Trop Dis 2023;17:e0011068. https:\/\/doi.org\/10.1371\/journal.pntd.0011068.","DOI":"10.1371\/journal.pntd.0011068"},{"key":"2026092111571358795_j_nipt-2026-0016_ref_053","doi-asserted-by":"crossref","unstructured":"Xu, J, Ganguly, A, Zhao, J, Ivey, M, Lopez, R, Osterholzer, JJ, et al.. CCR2 signaling promotes brain infiltration of inflammatory monocytes and contributes to neuropathology during cryptococcal meningoencephalitis. mBio 2021;12:e0107621. https:\/\/doi.org\/10.1128\/mbio.01076-21.","DOI":"10.1128\/mBio.01076-21"},{"key":"2026092111571358795_j_nipt-2026-0016_ref_054","doi-asserted-by":"crossref","unstructured":"Voelz, K, Lammas, DA, May, RC. Cytokine signaling regulates the outcome of intracellular macrophage parasitism by Cryptococcus neoformans. Infect Immun 2009;77:3450\u20137. https:\/\/doi.org\/10.1128\/iai.00297-09.","DOI":"10.1128\/IAI.00297-09"},{"key":"2026092111571358795_j_nipt-2026-0016_ref_055","doi-asserted-by":"crossref","unstructured":"Yauch, LE, Lam, JS, Levitz, SM. Direct inhibition of T-cell responses by the Cryptococcus capsular polysaccharide glucuronoxylomannan. PLoS Pathog 2006;2:e120. https:\/\/doi.org\/10.1371\/journal.ppat.0020120.","DOI":"10.1371\/journal.ppat.0020120"},{"key":"2026092111571358795_j_nipt-2026-0016_ref_056","doi-asserted-by":"crossref","unstructured":"Aguirre, K, Havell, EA, Gibson, GW, Johnson, LL. Role of tumor necrosis factor and gamma interferon in acquired resistance to Cryptococcus neoformans in the central nervous system of mice. Infect Immun 1995;63:1725\u201331. https:\/\/doi.org\/10.1128\/iai.63.5.1725-1731.1995.","DOI":"10.1128\/iai.63.5.1725-1731.1995"},{"key":"2026092111571358795_j_nipt-2026-0016_ref_057","doi-asserted-by":"crossref","unstructured":"Akilimali, NA, Chang, CC, Muema, DM, Reddy, T, Moosa, MS, Lewin, SR, et al.. Plasma but not cerebrospinal fluid interleukin 7 and interleukin 5 levels pre-antiretroviral therapy commencement predict cryptococcosis-associated immune reconstitution inflammatory syndrome. Clin Infect Dis 2017;65:1551\u20139. https:\/\/doi.org\/10.1093\/cid\/cix598.","DOI":"10.1093\/cid\/cix598"},{"key":"2026092111571358795_j_nipt-2026-0016_ref_058","doi-asserted-by":"crossref","unstructured":"Chang, CC, Dorasamy, AA, Gosnell, BI, Elliott, JH, Spelman, T, Omarjee, S, et al.. Clinical and mycological predictors of cryptococcosis-associated immune reconstitution inflammatory syndrome. AIDS 2013;27:2089\u201399. https:\/\/doi.org\/10.1097\/qad.0b013e3283614a8d.","DOI":"10.1097\/QAD.0b013e3283614a8d"},{"key":"2026092111571358795_j_nipt-2026-0016_ref_059","doi-asserted-by":"crossref","unstructured":"Muller, U, Stenzel, W, Kohler, G, Werner, C, Polte, T, Hansen, G, et al.. IL-13 induces disease-promoting type 2 cytokines, alternatively activated macrophages and allergic inflammation during pulmonary infection of mice with Cryptococcus neoformans. J Immunol 2007;179:5367\u201377. https:\/\/doi.org\/10.4049\/jimmunol.179.8.5367.","DOI":"10.4049\/jimmunol.179.8.5367"},{"key":"2026092111571358795_j_nipt-2026-0016_ref_060","doi-asserted-by":"crossref","unstructured":"Winters, MS, Chan, Q, Caruso, JA, Deepe, GSJr. Metallomic analysis of macrophages infected with Histoplasma capsulatum reveals a fundamental role for zinc in host defenses. J Infect Dis 2010;202:1136\u201345. https:\/\/doi.org\/10.1086\/656191.","DOI":"10.1086\/656191"},{"key":"2026092111571358795_j_nipt-2026-0016_ref_061","doi-asserted-by":"crossref","unstructured":"Diehl, S, Rincon, M. The two faces of IL-6 on Th1\/Th2 differentiation. Mol Immunol 2002;39:531\u20136. https:\/\/doi.org\/10.1016\/s0161-5890(02)00210-9.","DOI":"10.1016\/S0161-5890(02)00210-9"},{"key":"2026092111571358795_j_nipt-2026-0016_ref_062","doi-asserted-by":"crossref","unstructured":"Mackall, CL, Fry, TJ, Gress, RE. Harnessing the biology of IL-7 for therapeutic application. Nat Rev Immunol 2011;11:330\u201342. https:\/\/doi.org\/10.1038\/nri2970.","DOI":"10.1038\/nri2970"},{"key":"2026092111571358795_j_nipt-2026-0016_ref_063","doi-asserted-by":"crossref","unstructured":"Antonelli, LR, Mahnke, Y, Hodge, JN, Porter, BO, Barber, DL, DerSimonian, R, et al.. Elevated frequencies of highly activated CD4+ T cells in HIV+ patients developing immune reconstitution inflammatory syndrome. Blood 2010;116:3818\u201327. https:\/\/doi.org\/10.1182\/blood-2010-05-285080.","DOI":"10.1182\/blood-2010-05-285080"},{"key":"2026092111571358795_j_nipt-2026-0016_ref_064","doi-asserted-by":"crossref","unstructured":"Annunziato, F, Cosmi, L, Santarlasci, V, Maggi, L, Liotta, F, Mazzinghi, B, et al.. Phenotypic and functional features of human Th17 cells. J Exp Med 2007;204:1849\u201361. https:\/\/doi.org\/10.1084\/jem.20070663.","DOI":"10.1084\/jem.20070663"},{"key":"2026092111571358795_j_nipt-2026-0016_ref_065","doi-asserted-by":"crossref","unstructured":"De, BS, Bianchini, E, Nasi, M, Digaetano, M, Gibellini, L, Carnevale, G, et al.. Th1 and Th17 proinflammatory profile characterizes invariant natural killer T cells in virologically suppressed HIV+ patients with low CD4+\/CD8+ ratio. AIDS 2016;30:2599\u2013610. https:\/\/doi.org\/10.1097\/qad.0000000000001247.","DOI":"10.1097\/QAD.0000000000001247"},{"key":"2026092111571358795_j_nipt-2026-0016_ref_066","doi-asserted-by":"crossref","unstructured":"Korn, T, Bettelli, E, Oukka, M, Kuchroo, VK. IL-17 and Th17 cells. Annu Rev Immunol 2009;27:485\u2013517. https:\/\/doi.org\/10.1146\/annurev.immunol.021908.132710.","DOI":"10.1146\/annurev.immunol.021908.132710"},{"key":"2026092111571358795_j_nipt-2026-0016_ref_067","doi-asserted-by":"crossref","unstructured":"Ouyang, W, Kolls, JK, Zheng, Y. The biological functions of T helper 17 cell effector cytokines in inflammation. Immunity 2008;28:454\u201367. https:\/\/doi.org\/10.1016\/j.immuni.2008.03.004.","DOI":"10.1016\/j.immuni.2008.03.004"},{"key":"2026092111571358795_j_nipt-2026-0016_ref_068","doi-asserted-by":"crossref","unstructured":"Sun, L, Su, Y, Jiao, A, Wang, X, Zhang, B. T cells in health and disease. Signal Transduct Target Ther 2023;8:235. https:\/\/doi.org\/10.1038\/s41392-023-01471-y.","DOI":"10.1038\/s41392-023-01471-y"},{"key":"2026092111571358795_j_nipt-2026-0016_ref_069","doi-asserted-by":"crossref","unstructured":"Plitas, G, Rudensky, AY. Regulatory T cells: differentiation and function. Cancer Immunol Res 2016;4:721\u20135. https:\/\/doi.org\/10.1158\/2326-6066.cir-16-0193.","DOI":"10.1158\/2326-6066.CIR-16-0193"},{"key":"2026092111571358795_j_nipt-2026-0016_ref_070","doi-asserted-by":"crossref","unstructured":"Kimura, A, Kishimoto, T. IL-6: regulator of Treg\/Th17 balance. Eur J Immunol 2010;40:1830\u20135. https:\/\/doi.org\/10.1002\/eji.201040391.","DOI":"10.1002\/eji.201040391"},{"key":"2026092111571358795_j_nipt-2026-0016_ref_071","doi-asserted-by":"crossref","unstructured":"Li, D, Cruz, I, Feng, Y, Moussa, M, Cheng, J, Patil, D, et al.. Divergent immunomodulatory roles of fungal DNA in shaping Treg and inflammatory responses. J Fungi 2025;11. https:\/\/doi.org\/10.3390\/jof11110760.","DOI":"10.3390\/jof11110760"},{"key":"2026092111571358795_j_nipt-2026-0016_ref_072","doi-asserted-by":"crossref","unstructured":"Valdez, PA, Vithayathil, PJ, Janelsins, BM, Shaffer, AL, Williamson, PR, Datta, SK. Prostaglandin E2 suppresses antifungal immunity by inhibiting interferon regulatory factor 4 function and interleukin-17 expression in T cells. Immunity 2012;36:668\u201379. https:\/\/doi.org\/10.1016\/j.immuni.2012.02.013.","DOI":"10.1016\/j.immuni.2012.02.013"},{"key":"2026092111571358795_j_nipt-2026-0016_ref_073","doi-asserted-by":"crossref","unstructured":"Zhang, Y, Wang, F, Tompkins, KC, McNamara, A, Jain, AV, Moore, BB, et al.. Robust Th1 and Th17 immunity supports pulmonary clearance but cannot prevent systemic dissemination of highly virulent Cryptococcus neoformans H99. Am J Pathol 2009;175:2489\u2013500. https:\/\/doi.org\/10.2353\/ajpath.2009.090530.","DOI":"10.2353\/ajpath.2009.090530"},{"key":"2026092111571358795_j_nipt-2026-0016_ref_074","doi-asserted-by":"crossref","unstructured":"Hale, G, Adzemovic, T, Huppler Hullsiek, K, Mulwana, S, Ndyetukira, JF, Sadiq, A, et al.. Mid-upper arm circumference is a strong predictor of mortality among Ugandan adults with HIV-associated cryptococcal meningitis: a prospective cohort study. Open Forum Infect Dis 2024;11:ofae354. https:\/\/doi.org\/10.1093\/ofid\/ofae354.","DOI":"10.1093\/ofid\/ofae354"},{"key":"2026092111571358795_j_nipt-2026-0016_ref_075","doi-asserted-by":"crossref","unstructured":"Okurut, S, Boulware, DR, Manabe, YC, Tugume, L, Skipper, CP, Ssebambulidde, K, et al.. Impact of cerebrospinal fluid leukocyte infiltration and activated neuroimmune mediators on survival with HIV-associated cryptococcal meningitis. PLoS Negl Trop Dis 2025;19:e0012873. https:\/\/doi.org\/10.1371\/journal.pntd.0012873.","DOI":"10.1371\/journal.pntd.0012873"},{"key":"2026092111571358795_j_nipt-2026-0016_ref_076","doi-asserted-by":"crossref","unstructured":"Wen, L, Shi, L, Wan, SS, Xu, T, Zhang, L, Zhou, ZG. Changes in the balance of Th17\/Treg cells and oxidative stress markers in patients with HIV-associated pulmonary tuberculosis who develop IRIS. Exp Ther Med 2023;25:271. https:\/\/doi.org\/10.3892\/etm.2023.11970.","DOI":"10.3892\/etm.2023.11970"},{"key":"2026092111571358795_j_nipt-2026-0016_ref_077","doi-asserted-by":"crossref","unstructured":"Li, H, Hissong, R, Goughenour, KD, Sinitsyna, Y, Lintner, M, Song, B, et al.. Foxp3(+) regulatory T cells restrain Th1 response shielding the brain from lethal inflammatory damage during cryptococcal meningoencephalitis. Res Sq 2025. https:\/\/doi.org\/10.21203\/rs.3.rs-7142999\/v1.","DOI":"10.21203\/rs.3.rs-7142999\/v1"},{"key":"2026092111571358795_j_nipt-2026-0016_ref_078","doi-asserted-by":"crossref","unstructured":"Wong, CS, Buckner, CM, Lage, SL, Pei, L, Assis, FL, Dahlstrom, EW, et al.. Rapid emergence of T follicular helper and germinal center b cells following antiretroviral therapy in advanced HIV disease. Front Immunol 2021;12:752782. https:\/\/doi.org\/10.3389\/fimmu.2021.752782.","DOI":"10.3389\/fimmu.2021.752782"},{"key":"2026092111571358795_j_nipt-2026-0016_ref_079","doi-asserted-by":"crossref","unstructured":"Barros, N, Sanchez, CA, White, ACJr., Bauer, A, Woll, F, Graviss, EA, et al.. Regulatory T cells kinetics in immune reconstitution inflammatory syndrome in HIV-tuberculosis co-infected individuals. J Mol Clin Med 2025;8. https:\/\/doi.org\/10.31083\/jmcm25012.","DOI":"10.31083\/JMCM25012"},{"key":"2026092111571358795_j_nipt-2026-0016_ref_080","doi-asserted-by":"crossref","unstructured":"Bettelli, E, Carrier, Y, Gao, W, Korn, T, Strom, TB, Oukka, M, et al.. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006;441:235\u20138. https:\/\/doi.org\/10.1038\/nature04753.","DOI":"10.1038\/nature04753"},{"key":"2026092111571358795_j_nipt-2026-0016_ref_081","doi-asserted-by":"crossref","unstructured":"Veldhoen, M, Stockinger, B. TGFbeta1, a \u201cJack of all trades\u201d: the link with pro-inflammatory IL-17-producing T cells. Trends Immunol 2006;27:358\u201361. https:\/\/doi.org\/10.1016\/j.it.2006.06.001.","DOI":"10.1016\/j.it.2006.06.001"},{"key":"2026092111571358795_j_nipt-2026-0016_ref_082","doi-asserted-by":"crossref","unstructured":"Chang, CC, Omarjee, S, Lim, A, Spelman, T, Gosnell, BI, Carr, WH, et al.. Chemokine levels and chemokine receptor expression in the blood and the cerebrospinal fluid of HIV-infected patients with cryptococcal meningitis and cryptococcosis-associated immune reconstitution inflammatory syndrome. J Infect Dis 2013;208:1604\u201312. https:\/\/doi.org\/10.1093\/infdis\/jit388.","DOI":"10.1093\/infdis\/jit388"},{"key":"2026092111571358795_j_nipt-2026-0016_ref_083","doi-asserted-by":"crossref","unstructured":"Mackay, CR. CXCR3(+)CCR5(+) T cells and autoimmune diseases: guilty as charged? J Clin Invest 2014;124:3682\u20134. https:\/\/doi.org\/10.1172\/jci77837.","DOI":"10.1172\/JCI77837"},{"key":"2026092111571358795_j_nipt-2026-0016_ref_084","doi-asserted-by":"crossref","unstructured":"Luckheeram, RV, Zhou, R, Verma, AD, Xia, B. CD4(+)T cells: differentiation and functions. Clin Dev Immunol 2012;2012:925135. https:\/\/doi.org\/10.1155\/2012\/925135.","DOI":"10.1155\/2012\/925135"},{"key":"2026092111571358795_j_nipt-2026-0016_ref_085","doi-asserted-by":"crossref","unstructured":"Fazilleau, N, Mark, L, McHeyzer-Williams, LJ, McHeyzer-Williams, MG. Follicular helper T cells: lineage and location. Immunity 2009;30:324\u201335. https:\/\/doi.org\/10.1016\/j.immuni.2009.03.003.","DOI":"10.1016\/j.immuni.2009.03.003"},{"key":"2026092111571358795_j_nipt-2026-0016_ref_086","doi-asserted-by":"crossref","unstructured":"Lindqvist, M, van Lunzen, J, Soghoian, DZ, Kuhl, BD, Ranasinghe, S, Kranias, G, et al.. Expansion of HIV-specific T follicular helper cells in chronic HIV infection. J Clin Invest 2012;122:3271\u201380. https:\/\/doi.org\/10.1172\/jci64314.","DOI":"10.1172\/JCI64314"},{"key":"2026092111571358795_j_nipt-2026-0016_ref_087","doi-asserted-by":"crossref","unstructured":"Cubas, RA, Mudd, JC, Savoye, AL, Perreau, M, van Grevenynghe, J, Metcalf, T, et al.. Inadequate T follicular cell help impairs B cell immunity during HIV infection. Nat Med 2013;19:494\u20139. https:\/\/doi.org\/10.1038\/nm.3109.","DOI":"10.1038\/nm.3109"},{"key":"2026092111571358795_j_nipt-2026-0016_ref_088","doi-asserted-by":"crossref","unstructured":"Liu, Y, Li, Z, Lu, X, Kuang, YQ, Kong, D, Zhang, X, et al.. Dysregulation of memory B cells and circulating T follicular helper cells is a predictor of poor immune recovery in HIV-infected patients on antiretroviral therapy. J Med Virol 2023;95:e28559. https:\/\/doi.org\/10.1002\/jmv.28559.","DOI":"10.1002\/jmv.28559"},{"key":"2026092111571358795_j_nipt-2026-0016_ref_089","doi-asserted-by":"crossref","unstructured":"Liu, Z, Dai, H, Cui, X, Liu, Y, Dong, Z. Importance of B cells (Review). Int J Mol Med 2026;57.","DOI":"10.3892\/ijmm.2025.5673"},{"key":"2026092111571358795_j_nipt-2026-0016_ref_090","doi-asserted-by":"crossref","unstructured":"Rastogi, I, Jeon, D, Moseman, JE, Muralidhar, A, Potluri, HK, McNeel, DG. Role of B cells as antigen presenting cells. Front Immunol 2022;13:954936. https:\/\/doi.org\/10.3389\/fimmu.2022.954936.","DOI":"10.3389\/fimmu.2022.954936"},{"key":"2026092111571358795_j_nipt-2026-0016_ref_091","doi-asserted-by":"crossref","unstructured":"Torices, S, Iglesias Gallo, D, Lara, E, Simecek, S, Simon, S, Okoro, N, et al.. Targeting the CCL2\/CCR2 axis in HIV-1 infection and ischemic stroke. Stroke 2026;57:538\u201348. https:\/\/doi.org\/10.1161\/strokeaha.125.051965.","DOI":"10.1161\/STROKEAHA.125.051965"},{"key":"2026092111571358795_j_nipt-2026-0016_ref_092","doi-asserted-by":"crossref","unstructured":"Deffner, M, Schneider-Hohendorf, T, Schulte-Mecklenbeck, A, Falk, S, Lu, IN, Ostkamp, P, et al.. Chemokine-mediated cell migration into the central nervous system in progressive multifocal leukoencephalopathy. Cell Rep Med 2024;5:101622. https:\/\/doi.org\/10.1016\/j.xcrm.2024.101622.","DOI":"10.1016\/j.xcrm.2024.101622"},{"key":"2026092111571358795_j_nipt-2026-0016_ref_093","doi-asserted-by":"crossref","unstructured":"Yoon, HA, Nakouzi, A, Chang, CC, Kuniholm, MH, Carreno, LJ, Wang, T, et al.. Association between plasma antibody responses and risk for cryptococcus-associated immune reconstitution inflammatory syndrome. J Infect Dis 2019;219:420\u20138. https:\/\/doi.org\/10.1093\/infdis\/jiy447.","DOI":"10.1093\/infdis\/jiy447"},{"key":"2026092111571358795_j_nipt-2026-0016_ref_094","doi-asserted-by":"crossref","unstructured":"Dufaud, C, Rivera, J, Rohatgi, S, Pirofski, LA. Naive B cells reduce fungal dissemination in Cryptococcus neoformans infected Rag1(-\/-) mice. Virulence 2018;9:173\u201384. https:\/\/doi.org\/10.1080\/21505594.2017.1370529.","DOI":"10.1080\/21505594.2017.1370529"},{"key":"2026092111571358795_j_nipt-2026-0016_ref_095","doi-asserted-by":"crossref","unstructured":"Trevijano-Contador, N, Pianalto, KM, Nichols, CB, Zaragoza, O, Alspaugh, JA, Pirofski, LA. Human IgM inhibits the formation of titan-like cells in Cryptococcus neoformans. Infect Immun 2020;88. https:\/\/doi.org\/10.1128\/iai.00046-20.","DOI":"10.1128\/IAI.00046-20"},{"key":"2026092111571358795_j_nipt-2026-0016_ref_096","doi-asserted-by":"crossref","unstructured":"Rohatgi, S, Pirofski, LA. Host immunity to Cryptococcus neoformans. Future Microbiol 2015;10:565\u201381. https:\/\/doi.org\/10.2217\/fmb.14.132.","DOI":"10.2217\/fmb.14.132"},{"key":"2026092111571358795_j_nipt-2026-0016_ref_097","doi-asserted-by":"crossref","unstructured":"Yoon, H, Nakouzi, AS, Duong, VA, Hung, LQ, Binh, TQ, Tung, NLN, et al.. Shared and unique antibody and B cell profiles in HIV-positive and HIV-negative individuals with cryptococcal meningoencephalitis. Med Mycol 2023;61. https:\/\/doi.org\/10.1093\/mmy\/myad102.","DOI":"10.1093\/mmy\/myad102"},{"key":"2026092111571358795_j_nipt-2026-0016_ref_098","doi-asserted-by":"crossref","unstructured":"Rachini, A, Pietrella, D, Lupo, P, Torosantucci, A, Chiani, P, Bromuro, C, et al.. An anti-beta-glucan monoclonal antibody inhibits growth and capsule formation of Cryptococcus neoformans in vitro and exerts therapeutic, anticryptococcal activity in vivo. Infect Immun 2007;75:5085\u201394. https:\/\/doi.org\/10.1128\/iai.00278-07.","DOI":"10.1128\/IAI.00278-07"},{"key":"2026092111571358795_j_nipt-2026-0016_ref_099","doi-asserted-by":"crossref","unstructured":"Takatsu, K. Interleukin 5 and B cell differentiation. Cytokine Growth Factor Rev 1998;9:25\u201335. https:\/\/doi.org\/10.1016\/s1359-6101(97)00034-8.","DOI":"10.1016\/S1359-6101(97)00034-8"},{"key":"2026092111571358795_j_nipt-2026-0016_ref_100","doi-asserted-by":"crossref","unstructured":"Corfe, SA, Paige, CJ. The many roles of IL-7 in B cell development; mediator of survival, proliferation and differentiation. Semin Immunol 2012;24:198\u2013208. https:\/\/doi.org\/10.1016\/j.smim.2012.02.001.","DOI":"10.1016\/j.smim.2012.02.001"},{"key":"2026092111571358795_j_nipt-2026-0016_ref_101","doi-asserted-by":"crossref","unstructured":"Bemark, M, Angeletti, D. Know your enemy or find your friend? Induction of IgA at mucosal surfaces. Immunol Rev 2021;303:83\u2013102. https:\/\/doi.org\/10.1111\/imr.13014.","DOI":"10.1111\/imr.13014"},{"key":"2026092111571358795_j_nipt-2026-0016_ref_102","doi-asserted-by":"crossref","unstructured":"Khaw, YM, Aggarwal, N, Barclay, WE, Kang, E, Inoue, M, Shinohara, ML. Th1-dependent Cryptococcus-associated immune reconstitution inflammatory syndrome model with brain damage. Front Immunol 2020;11:529219. https:\/\/doi.org\/10.3389\/fimmu.2020.529219.","DOI":"10.3389\/fimmu.2020.529219"},{"key":"2026092111571358795_j_nipt-2026-0016_ref_103","doi-asserted-by":"crossref","unstructured":"Fiorio, LM, Biasutti, C, Rosa-Junior, M. Cryptococcus gattii infection complicated by immune reconstitution syndrome in a patient with common variable immunodeficiency. Rev Soc Bras Med Trop 2022;55. https:\/\/doi.org\/10.1590\/0037-8682-0443-2022.","DOI":"10.1590\/0037-8682-0443-2022"},{"key":"2026092111571358795_j_nipt-2026-0016_ref_104","doi-asserted-by":"crossref","unstructured":"Okudo, J, Civelli, VF, Narang, VK, Johnson, RH, Khan, N, Andruszko, B, et al.. A rare case of Cryptococcus gattii meningitis in advanced HIV disease, sagittal thrombosis, and immune reconstitution syndrome, resolved with isavuconazonium. J Invest Med High Impact Case Rep 2020;8:2324709620959880. https:\/\/doi.org\/10.1177\/2324709620959880.","DOI":"10.1177\/2324709620959880"},{"key":"2026092111571358795_j_nipt-2026-0016_ref_105","doi-asserted-by":"crossref","unstructured":"Speed, BR, Kaldor, J, Cairns, B, Pegorer, M. Serum antibody response to active infection with Cryptococcus neoformans and its varieties in immunocompetent subjects. J Med Vet Mycol 1996;34:187\u201393. https:\/\/doi.org\/10.1080\/02681219680000311.","DOI":"10.1080\/02681219680000311"},{"key":"2026092111571358795_j_nipt-2026-0016_ref_106","doi-asserted-by":"crossref","unstructured":"Anwar, S, Zhou, J, Kowalski, L, Saylor, J, Shukla, D, Boetel, K, et al.. Star-shaped glatiramer acetate mitigates pulmonary dysfunction and brain neuroinflammation in a murine model of cryptococcus-associated IRIS. Biomedicines 2025;13. https:\/\/doi.org\/10.3390\/biomedicines13112835.","DOI":"10.1101\/2025.01.07.631707"},{"key":"2026092111571358795_j_nipt-2026-0016_ref_107","doi-asserted-by":"crossref","unstructured":"Tselis, A, Khan, O, Lisak, RP. Glatiramer acetate in the treatment of multiple sclerosis. Neuropsychiatr Dis Treat 2007;3:259\u201367. https:\/\/doi.org\/10.2147\/nedt.2007.3.2.259.","DOI":"10.2147\/nedt.2007.3.2.259"},{"key":"2026092111571358795_j_nipt-2026-0016_ref_108","doi-asserted-by":"crossref","unstructured":"Aharoni, R, Kayhan, B, Eilam, R, Sela, M, Arnon, R. Glatiramer acetate-specific T cells in the brain express T helper 2\/3 cytokines and brain-derived neurotrophic factor in situ. Proc Natl Acad Sci U S A 2003;100:14157\u201362. https:\/\/doi.org\/10.1073\/pnas.2336171100.","DOI":"10.1073\/pnas.2336171100"},{"key":"2026092111571358795_j_nipt-2026-0016_ref_109","doi-asserted-by":"crossref","unstructured":"Schrempf, W, Ziemssen, T. Glatiramer acetate: mechanisms of action in multiple sclerosis. Autoimmun Rev 2007;6:469\u201375.","DOI":"10.1016\/j.autrev.2007.02.003"},{"key":"2026092111571358795_j_nipt-2026-0016_ref_110","doi-asserted-by":"crossref","unstructured":"Bottlaender, L, Seve, P, Cotte, L, Gerfaud-Valentin, M, Jamilloux, Y. Successful treatment with anakinra of an HIV-associated immune reconstitution inflammatory syndrome mimicking adult-onset Still\u2019s disease. Rheumatology 2019;58:363\u20135. https:\/\/doi.org\/10.1093\/rheumatology\/key291.","DOI":"10.1093\/rheumatology\/key291"},{"key":"2026092111571358795_j_nipt-2026-0016_ref_111","doi-asserted-by":"crossref","unstructured":"Keeley, AJ, Parkash, V, Tunbridge, A, Greig, J, Collini, P, McKane, W, et al.. Anakinra in the treatment of protracted paradoxical inflammatory reactions in HIV-associated tuberculosis in the United Kingdom: a report of two cases. Int J STD AIDS 2020;31:808\u201312. https:\/\/doi.org\/10.1177\/0956462420915394.","DOI":"10.1177\/0956462420915394"},{"key":"2026092111571358795_j_nipt-2026-0016_ref_112","doi-asserted-by":"crossref","unstructured":"Sitapati, AM, Kao, CL, Cachay, ER, Masoumi, H, Wallis, RS, Mathews, WC. Treatment of HIV-related inflammatory cerebral cryptococcoma with adalimumab. Clin Infect Dis 2010;50:e7\u201310. https:\/\/doi.org\/10.1086\/649553.","DOI":"10.1086\/649553"},{"key":"2026092111571358795_j_nipt-2026-0016_ref_113","doi-asserted-by":"crossref","unstructured":"Al Khzem, AH, Wali, SM. Drug repurposing as an effective drug discovery strategy: a critical review. Drug Des Dev Ther 2025;19:12019\u201334. https:\/\/doi.org\/10.2147\/dddt.s576701.","DOI":"10.2147\/DDDT.S576701"},{"key":"2026092111571358795_j_nipt-2026-0016_ref_114","doi-asserted-by":"crossref","unstructured":"Saijo, T, Chen, J, Chen, SC, Rosen, LB, Yi, J, Sorrell, TC, et al.. Anti-granulocyte-macrophage colony-stimulating factor autoantibodies are a risk factor for central nervous system infection by Cryptococcus gattii in otherwise immunocompetent patients. mBio 2014;5:e00912-14. https:\/\/doi.org\/10.1128\/mbio.00912-14.","DOI":"10.1128\/mBio.00912-14"},{"key":"2026092111571358795_j_nipt-2026-0016_ref_115","doi-asserted-by":"crossref","unstructured":"Armstrong-James, D, Brown, GD, Netea, MG, Zelante, T, Gresnigt, MS, van de Veerdonk, FL, et al.. Immunotherapeutic approaches to treatment of fungal diseases. Lancet Infect Dis 2017;17:e393\u2013402. https:\/\/doi.org\/10.1016\/s1473-3099(17)30442-5.","DOI":"10.1016\/S1473-3099(17)30442-5"},{"key":"2026092111571358795_j_nipt-2026-0016_ref_116","doi-asserted-by":"crossref","unstructured":"Kullberg, BJ, van \u2019t Wout, JW, Hoogstraten, C, van Furth, R. Recombinant interferon-gamma enhances resistance to acute disseminated Candida albicans infection in mice. J Infect Dis 1993;168:436\u201343. https:\/\/doi.org\/10.1093\/infdis\/168.2.436.","DOI":"10.1093\/infdis\/168.2.436"},{"key":"2026092111571358795_j_nipt-2026-0016_ref_117","doi-asserted-by":"crossref","unstructured":"Saylor, C, Dadachova, E, Casadevall, A. Monoclonal antibody-based therapies for microbial diseases. Vaccine 2009;27:G38\u201346. https:\/\/doi.org\/10.1016\/j.vaccine.2009.09.105.","DOI":"10.1016\/j.vaccine.2009.09.105"},{"key":"2026092111571358795_j_nipt-2026-0016_ref_118","doi-asserted-by":"crossref","unstructured":"Boniche, C, Rossi, SA, Kischkel, B, Barbalho, FV, Moura, AND, Nosanchuk, JD, et al.. Immunotherapy against systemic fungal infections based on monoclonal antibodies. J Fungi 2020;6. https:\/\/doi.org\/10.3390\/jof6010031.","DOI":"10.3390\/jof6010031"},{"key":"2026092111571358795_j_nipt-2026-0016_ref_119","doi-asserted-by":"crossref","unstructured":"Sam, QH, Yew, WS, Seneviratne, CJ, Chang, MW, Chai, LYA. Immunomodulation as therapy for fungal infection: are we closer? Front Microbiol 2018;9:1612. https:\/\/doi.org\/10.3389\/fmicb.2018.01612.","DOI":"10.3389\/fmicb.2018.01612"},{"key":"2026092111571358795_j_nipt-2026-0016_ref_120","doi-asserted-by":"crossref","unstructured":"Schmidt, S, Tramsen, L, Hanisch, M, Latge, JP, Huenecke, S, Koehl, U, et al.. Human natural killer cells exhibit direct activity against Aspergillus fumigatus hyphae, but not against resting conidia. J Infect Dis 2011;203:430\u20135. https:\/\/doi.org\/10.1093\/infdis\/jiq062.","DOI":"10.1093\/infdis\/jiq062"},{"key":"2026092111571358795_j_nipt-2026-0016_ref_121","doi-asserted-by":"crossref","unstructured":"Schmidt, S, Tramsen, L, Perkhofer, S, Lass-Florl, C, Hanisch, M, Roger, F, et al.. Rhizopus oryzae hyphae are damaged by human natural killer (NK) cells, but suppress NK cell mediated immunity. Immunobiology 2013;218:939\u201344. https:\/\/doi.org\/10.1016\/j.imbio.2012.10.013.","DOI":"10.1016\/j.imbio.2012.10.013"},{"key":"2026092111571358795_j_nipt-2026-0016_ref_122","doi-asserted-by":"crossref","unstructured":"Kumaresan, PR, Manuri, PR, Albert, ND, Maiti, S, Singh, H, Mi, T, et al.. Bioengineering T cells to target carbohydrate to treat opportunistic fungal infection. Proc Natl Acad Sci U S A 2014;111:10660\u20135. https:\/\/doi.org\/10.1073\/pnas.1312789111.","DOI":"10.1073\/pnas.1312789111"},{"key":"2026092111571358795_j_nipt-2026-0016_ref_123","doi-asserted-by":"crossref","unstructured":"da Silva, TA, Hauser, PJ, Bandey, I, Laskowski, T, Wang, Q, Najjar, AM, et al.. Glucuronoxylomannan in the Cryptococcus species capsule as a target for chimeric antigen receptor T-cell therapy. Cytotherapy 2021;23:119\u201330. https:\/\/doi.org\/10.1016\/j.jcyt.2020.11.002.","DOI":"10.1016\/j.jcyt.2020.11.002"},{"key":"2026092111571358795_j_nipt-2026-0016_ref_124","doi-asserted-by":"crossref","unstructured":"Oliveira, LVN, Wang, R, Specht, CA, Levitz, SM. Vaccines for human fungal diseases: close but still a long way to go. NPJ Vaccines 2021;6:33. https:\/\/doi.org\/10.1038\/s41541-021-00294-8.","DOI":"10.1038\/s41541-021-00294-8"},{"key":"2026092111571358795_j_nipt-2026-0016_ref_125","doi-asserted-by":"crossref","unstructured":"Nanjappa, SG, Klein, BS. Vaccine immunity against fungal infections. Curr Opin Immunol 2014;28:27\u201333. https:\/\/doi.org\/10.1016\/j.coi.2014.01.014.","DOI":"10.1016\/j.coi.2014.01.014"},{"key":"2026092111571358795_j_nipt-2026-0016_ref_126","doi-asserted-by":"crossref","unstructured":"Stempinski, PR, Rodrigues Dos Santos Junior, S, Casadevall, A. mGem: progress on the development of conjugate vaccines for Cryptococcus neoformans infections. mBio 2026;17:e0353825. https:\/\/doi.org\/10.1128\/mbio.03538-25.","DOI":"10.1128\/mbio.03538-25"},{"key":"2026092111571358795_j_nipt-2026-0016_ref_127","doi-asserted-by":"crossref","unstructured":"Datta, K, Lees, A, Pirofski, LA. Therapeutic efficacy of a conjugate vaccine containing a peptide mimotope of cryptococcal capsular polysaccharide glucuronoxylomannan. Clin Vaccine Immunol 2008;15:1176\u201387. https:\/\/doi.org\/10.1128\/cvi.00130-08.","DOI":"10.1128\/CVI.00130-08"},{"key":"2026092111571358795_j_nipt-2026-0016_ref_128","doi-asserted-by":"crossref","unstructured":"Devi, SJ. Preclinical efficacy of a glucuronoxylomannan-tetanus toxoid conjugate vaccine of Cryptococcus neoformans in a murine model. Vaccine 1996;14:841\u20134. https:\/\/doi.org\/10.1016\/0264-410x(95)00256-z.","DOI":"10.1016\/0264-410X(95)00256-Z"},{"key":"2026092111571358795_j_nipt-2026-0016_ref_129","doi-asserted-by":"crossref","unstructured":"Crawford, CJ, Liporagi-Lopes, L, Coelho, C, Santos Junior, SR, Moraes Nicola, A, Wear, MP, et al.. Semisynthetic glycoconjugate vaccine candidates against Cryptococcus neoformans. ACS Infect Dis 2024;10:2089\u2013100. https:\/\/doi.org\/10.1021\/acsinfecdis.4c00094.","DOI":"10.1021\/acsinfecdis.4c00094"},{"key":"2026092111571358795_j_nipt-2026-0016_ref_130","doi-asserted-by":"crossref","unstructured":"Maiden, MC. The impact of protein-conjugate polysaccharide vaccines: an endgame for meningitis? Philos Trans R Soc London B 2013;368:20120147. https:\/\/doi.org\/10.1098\/rstb.2012.0147.","DOI":"10.1098\/rstb.2012.0147"},{"key":"2026092111571358795_j_nipt-2026-0016_ref_131","doi-asserted-by":"crossref","unstructured":"Rella, A, Mor, V, Farnoud, AM, Singh, A, Shamseddine, AA, Ivanova, E, et al.. Role of Sterylglucosidase 1 (Sgl1) on the pathogenicity of Cryptococcus neoformans: potential applications for vaccine development. Front Microbiol 2015;6:836. https:\/\/doi.org\/10.3389\/fmicb.2015.00836.","DOI":"10.3389\/fmicb.2015.00836"},{"key":"2026092111571358795_j_nipt-2026-0016_ref_132","doi-asserted-by":"crossref","unstructured":"Watanabe, T, Ito, T, Goda, HM, Ishibashi, Y, Miyamoto, T, Ikeda, K, et al.. Sterylglucoside catabolism in Cryptococcus neoformans with endoglycoceramidase-related protein 2 (EGCrP2), the first steryl-beta-glucosidase identified in fungi. J Biol Chem 2015;290:1005\u201319. https:\/\/doi.org\/10.1074\/jbc.m114.616300.","DOI":"10.1074\/jbc.M114.616300"},{"key":"2026092111571358795_j_nipt-2026-0016_ref_133","doi-asserted-by":"crossref","unstructured":"Normile, TG, Rella, A, Del Poeta, M. Cryptococcus neoformans Deltasgl1 vaccination requires either CD4(+) or CD8(+) T cells for complete host protection. Front Cell Infect Microbiol 2021;11:739027. https:\/\/doi.org\/10.3389\/fcimb.2021.739027.","DOI":"10.3389\/fcimb.2021.739027"},{"key":"2026092111571358795_j_nipt-2026-0016_ref_134","doi-asserted-by":"crossref","unstructured":"Li, F, Yu, X, Li, M, Ning, X, Zhou, K. Cryptococcal infection: host immunity, immune evasion and emerging immunotherapeutic strategies. Front Cell Infect Microbiol 2025;15:1671873. https:\/\/doi.org\/10.3389\/fcimb.2025.1671873.","DOI":"10.3389\/fcimb.2025.1671873"},{"key":"2026092111571358795_j_nipt-2026-0016_ref_135","doi-asserted-by":"crossref","unstructured":"Rizzo, J, Wong, SSW, Gazi, AD, Moyrand, F, Chaze, T, Commere, PH, et al.. Cryptococcus extracellular vesicles properties and their use as vaccine platforms. J Extracell Vesicles 2021;10:e12129. https:\/\/doi.org\/10.1002\/jev2.12129.","DOI":"10.1002\/jev2.12129"}],"container-title":["NeuroImmune Pharmacology and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/nipt-2026-0016\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/nipt-2026-0016\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T12:03:46Z","timestamp":1789992226000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/nipt-2026-0016\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,24]]},"references-count":135,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,9,22]]},"published-print":{"date-parts":[[2026,9,25]]}},"alternative-id":["10.1515\/nipt-2026-0016"],"URL":"https:\/\/doi.org\/10.1515\/nipt-2026-0016","relation":{},"ISSN":["2750-6665"],"issn-type":[{"value":"2750-6665","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,24]]}}}